Results 241 to 250 of about 139,259 (310)

Tetraspanin‐ESCRT sorting drives miR‐29b packaging into extracellular vesicles to reverse fibrosis in intrauterine adhesions

BMEMat, EarlyView.
MiR‐29b is enriched in extracellular vesicles (EVs) via a tetraspanin transporter‐dependent endocytosis and sorting complex required for the endosomal transport (ESCRT)‐dependent pathway. These EVs target the 3′ untranslated region (3′UTR) of TGFB2, thereby inhibiting the TGF‐β/Smad3 signaling pathway and repairing endometrial damage in intrauterine ...
Lihao Chen, Jianfeng Wu, Shunhan Zhang, Siqi Huang, Yingjun Xie, Hongda Chen, Yinghong Yang, Lan Xiao, Ding Wang, Keke Wu, Xiaofang Sun   +10 more
wiley   +1 more source

Survey on Dental Students' Knowledge of Infection Prevention and Control Rules. [PDF]

Dent J (Basel)
Stoeva V, Miteva-Katrandzhieva T, Shamsee E.   +2 more
europepmc   +1 more source

Circular Economy in the Healthcare Industry: Developing a Circularity Assessment Tool for Complex Medical Devices

Business Strategy and the Environment, EarlyView.
ABSTRACT As the circular economy transition gains traction in the healthcare sector, extending the lifespan of complex medical devices has become a key priority, given their high cost and the challenges associated with their technological sophistication.
Tetiana Shevchenko, Lauren Durivault, Meisam Ranjbari, Zahra Shams Esfandabadi, Bernard Yannou, Robert Heidsieck, Michael Saidani, Ghada Bouillass   +7 more
wiley   +1 more source

Alternative Disinfection in Hot Water Networks: Persistence and Antimicrobial Efficacy of Silver-Stabilized Hydrogen Peroxide for <i>Legionella pneumophila</i> Control. [PDF]

ACS ES T Water
Clark N, McCarthy LH, Liss SN.
europepmc   +1 more source

Goal Displacement and Goal Conflicts in Circular Innovation Initiatives: Types and Mitigation Practices

Business Strategy and the Environment, EarlyView.
ABSTRACT Many firms set ambitious sustainability goals but these are frequently “displaced” by proxy goals that are easier to track and measure. However, the specific types of goal conflicts that follow from this displacement are poorly understood. We conducted a case study of circular innovation initiatives at a global MedTech company and identified ...
Wiebke Reim, Johan Frishammar, Debadrita Panda   +2 more
wiley   +1 more source

Investigation of microbiological non-compliance of endoscopic final rinse water associated with opportunistic premise plumbing pathogens contamination in connecting tube. [PDF]

Sci Rep
Liu M, Zu Q, Zheng L, Wen L, Li S, Nie Y, Chen F, Zhang Q.   +7 more
europepmc   +1 more source

Sustaining Circular Innovation Under Volatile Market Conditions: The Critical Role of Industry Platforms

Business Strategy and the Environment, EarlyView.
ABSTRACT While industry platforms are widely recognized as enablers of circular innovation, we still know little about how they evolve to scale and sustain innovation as economic conditions tighten and circular economy funding schemes become more selective.
Eva Qi Wang, Julia A. Fehrer, Jonathan J. Baker, Roderick J. Brodie   +3 more
wiley   +1 more source

Leadership and healthcare professionals' role in hand hygiene compliance: Identifying risk factors at surgical clinics of the university clinical center NIS, Serbia. [PDF]

J Public Health Res
Marinkovic M, Djordjevic M, Djordjevic V, Karanikolic V, Novak S, Perisic J.   +5 more
europepmc   +1 more source

Perigraftitis, an independent biologic complication associated with implants placed in grafted bone

Clinical Advances in Periodontics, EarlyView.
Abstract Background Perigraftitis is a recently introduced concept describing biologic complications specifically associated with implants placed in grafted bone. It is characterized by inflammation resulting from bacterial colonization of grafted bone and/or residual graft particulates.
Jonathan H. Do, Charles M. Cobb, John T. Shen   +2 more
wiley   +1 more source

Extended Barrier Precautions vs Hand Hygiene Alone and Neonatal Sepsis in Intensive Care Patients: The BALTIC Cluster-Randomized Clinical Trial.

JAMA Netw Open
Faust K, Strecker F, Haug C, Felderhoff-Müser U, Stein A, Jensen R, Fortmann MI, Marißen J, Silwedel C, Brebach K, Frommhold D, Wieg C, Hillebrand G, Naust B, Schmidt E, Koch L, Schmidtke S, Simon A, Zemlin M, Meyer S, Scholzen C, Köstlin-Gille N, Gille C, Longardt AC, Göpel W, Krone M, Kampmeier S, Nurjadi D, Herting E, Rupp J, König IR, Härtel C.   +31 more
europepmc   +1 more source